Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vycor Medical (VYCO) Revenue (2016 - 2025)

Vycor Medical has reported Revenue over the past 16 years, most recently at $416877.0 for Q4 2025.

  • Quarterly Revenue fell 8.42% to $416877.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Dec 2025, up 17.24% year-over-year, with the annual reading at $1.9 million for FY2025, 17.24% up from the prior year.
  • Revenue was $416877.0 for Q4 2025 at Vycor Medical, down from $513792.0 in the prior quarter.
  • Over five years, Revenue peaked at $513792.0 in Q3 2025 and troughed at $271264.0 in Q4 2022.
  • The 5-year median for Revenue is $348981.0 (2023), against an average of $376465.2.
  • Year-over-year, Revenue surged 101.19% in 2021 and then tumbled 33.27% in 2022.
  • A 5-year view of Revenue shows it stood at $273724.0 in 2021, then fell by 0.9% to $271264.0 in 2022, then increased by 13.63% to $308249.0 in 2023, then skyrocketed by 47.68% to $455226.0 in 2024, then dropped by 8.42% to $416877.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Revenue are $416877.0 (Q4 2025), $513792.0 (Q3 2025), and $496353.0 (Q2 2025).